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odophyllin is the crude
extract from the roots
and rhizomes of two
plants from India, Podophyllum peltatum
and Podophyllum emodi (Arnold, 1979;
Issel and Crooke, 1979). Podophyllotoxin,
a main active constituent of podophyllin,
is known to produce metaphase arrest. It
binds tubulin at a distinct site from that
occupied by the vinca alkaloids, inhibit-
ing microtubule formation in the mitotic
spindle apparatus. However, it is too
toxic for clinical use (Chen et al., 1984).
Thus, attempting to discover less toxic
substances, two semi-synthetic glycosidic
derivatives of epipodophyllotoxin were
synthesized (Stähelin, 1973): the etopo-
side (Vepesid, code VP-16-213, abbrevi-
ated VP-16) and the teniposide (VM-26).
In the 70s, these derivatives obtained ap-
probation from the FDA for clinical use.
Unlike podophyllotoxin, etoposide has no
effect on microtubule assembly. It does
not arrest mitosis (Chen et al., 1984) but,
rather, exerts its maximal effects in the S
or G2 cell cycle phases preventing cells
from entering mitosis (Calabresi and
Parks, 1985).
The etoposide (4’-Deme-
thylepipodophyllotoxin-9-(4,6-O-ethyl-
idene-β-D-glucopyranoside) has been uti-
lized in a wide variety of neoplasms in-
cluding small-cell lung cancer, esophagic
carcinoma, Kaposi’s sarcoma, testicular
cancer, acute leukemia and, both Hodg-
kin’s and non Hodgkin’s lymphomas (Ko-
bayashi and Ratain, 1994).
The main target of this
drug is topoisomerase II (Minocha and
Long, 1984), and for this reason it is
known as “poison of topoisomerase” like
other drugs such as anthracyclines which
have a similar mechanism of action (Joel
et al., 1994; Joel and Slevin, 1994). In
spite of the beneficial effects of this drug
in malignant tumor treatment, some re-
ports have also emphasized a deleterious
action on the organism of mammals, in-
cluding the testes (Wozniak and Ross,
1983; Takahashi et al., 1986a; Kadota et
al., 1989). The myelossupression and go-
nadal failure (Myers and Schilsky, 1992)
are the two most common side effects re-
lated to the use of cytotoxic anticancer
agents. The implications of histological
data on reproductive performance must
be considered, mainly in young adult and
child patients, since there is a potential
risk of loss or diminution of the repro-
ductive capacity in etoposide-treated indi-
viduals. Such risk is commonly present
when chemotherapeutic drugs are utilized
in single as well as in multiple schedules
(Russell and Russell, 1991). In addition,
there are evidences that etoposide may be
more effective and/or less toxic when ad-
ministered in low divided daily doses
given for prolonged periods (Greco and
Hainswort, 1994). Animal studies carried
out in early 1970 demonstrated evident
superiority of more extended schedules of
etoposide administration against tumor
cell lineage (Russell and Russell, 1991;
Myers and Schilsky, 1992; Joel et al.,
1994). Moreover, clinical and experimen-
tal data related to the adverse late effects
of the etoposide treatment on testicular
morphology are scanty and fragmentary.
The present investigation aims to eluci-
date which quantitative and qualitative
changes of seminiferous epithelium can
be related to testicular atrophy in adult
rats (Kadota et al., 1989) treated chroni-
cally from prepuberal phase with low
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daily doses of etoposide. A histomorpho-
metric and stereological study was car-
ried out, and the serum testosterone level
and reproductive performance of the ani-
mals were investigated in the adult state.
In addition, since this drug is also mu-
tagenic (Maraschin et al., 1990) and
clastogenic (Agarwal et al., 1994), the
body weight, viability and mortality index
of the offspring were also observed.
Material and Methods
Animals and groups
Forty-eight male albino
Wistar 30-day old rats were distributed
among six groups and were sacrificed at
either 60 or 113 days of age (Table I).
Two of the groups received Vepesid
(VP16-213), the etoposide-experimental
(E60) and the mated etoposide-experimen-
tal (EM113) groups; two other groups re-
ceived the vehicle, the vehicle-experimen-
tal group (V60) and the mated vehicle-ex-
perimental group (VM113); the two re-
maining groups were control groups, in-
cluding the sham-control group (C60) and
the mated sham-control group (CM113).
Animals were allocated to the treatment
groups in a randomized manner and ob-
tained from different progenies. No more
than six newborn rats were maintained
during the period of breast-feeding, with
the aim to equalize their body weights at
the start of the treatments. The mated
groups (CM113, EM113 and VM113) had
ten animals each, while each of the other
groups included six rats.
All animals were kept in
plastic cages under 12-12 hour light cycle
at 23-25°C. Food and water were allowed
ad libitum. The general physiological
state of the animals was watched during
the treatment with the etoposide, although
the control of the blood cells was not
carried out. Principles of laboratory ani-
mal care (NIH publication 85-23, 1985)
and national laws on animal use were ob-
served. This research had approval from
the Ethical Committees of the Federal
University of São Paulo and the São
Paulo Hospital.
Dosage and schedule
Vepesid® ampoules (VP16-
213, Bristol–Myers Squibb) were utilized.
The contents of 5ml ampoules, (100mg
of etoposide each) were diluted in the ve-
hicle. The vehicle contained 650mg poly-
ethylene glycol 300, 30mg benzyl alco-
hol, 1mg citric acid, 80mg Tween 80 and
241mg ethyl alcohol per ml. Dosage so-
lutions of etoposide were prepared by di-
lution of each ampoule with 0.9% physi-
ological saline according to the timetable
from Bristol Myers Squibb. The rats in
the vehicle-experimental groups (V60 and
VM113) received the vehicle solution di-
luted with physiological saline; those in
the sham-control groups (C60 and C113)
received only physiological saline; while
rats in the experimental groups (E60 and
EM113) received 2mg/kg of body weight
(bw) of etoposide. The animals were sub-
jected to each specific treatment for 30
consecutive days from the prepuberal
phase, when they were 30 days old
(Table I). Intraperitoneal injection was
preferred over intravenous injection be-
cause of ease of administration. Lu and
Meistrich (1979) have shown that both
methods of administration generally yield
similar results. The long-term administra-
tion of low-daily-dose etoposide was uti-
lized in this report and its use in patients
has been suggested (Greco and Hains-
wort, 1994).
 Initially, the dosage was
established according to the literature. In
addition, a pilot test using different doses
was previously run. The dosage was se-
lected taking into account the testicular
morphological response and the adequate
mating conditions of the animals. After
the end of the experiment, thirty animals
of the EM113, VM113 and CM113
groups were maintained for 53 days to
assess their fertility, as the duration of
spermatogenesis in Wistar rats is of 52
days (Huckins,1965).
Histological and mating procedures
The rats were anaesthe-
tized with sodium pentobarbital (40mg/kg
bw). Their testes were dissected, removed
from the scrota and weighed. A microme-
ter caliper was utilized to measure major
and minor axes; and the gonads were
then fixed by immersion in Bouin’s liquid
for 48h. Cross and oblique random sec-
tions were obtained from the fragments
of the gonad, allowing a sequential ad-
equate morphometric and stereological
analysis (Gundersen et al., 1988; Manda-
rim-de-Lacerda, 1999). The specimens
were processed and embedded in para-
plast-plus. To obtain a better identifica-
tion of all phases of spermatogenesis,
3µm-thick sections were stained with the
periodic acid-Schiff method and counter-
stained with Harris’Hematoxylin (PAS +
H).
Morphometric and stereological studies
Testicular weight and testis total volume.
The testis is an ellipsoid (Ahmad et al.,
1969). Thus, the total volume of each
testis was calculated by the modified for-
mula of ellipsoid volume: V= 4/3·p·a·b2,
where a is the semiprolate axis and b is
the semioblate axis (Miraglia and Ha-
yashi, 1993; Botelho Cabral et al., 1997).
The absolute and relative testicular
weights were also determined (Table II).
Volume density. Volume densities (Vv) of
both seminiferous tubules and interstitial
tissue were calculated (Gundersen et al.,
1988). These values were obtained using a
25-point integrating eyepiece attached to a
light binocular microscope (Weibel, 1963).
One thousand points in 40 fields of tes-
ticular sections were randomly counted per
testis at x100 magnification. Based on
these data (Table III) and on the total tes-
ticular volume, the volumes of the corre-
spondent testicular components were cal-
culated (Miraglia and Hayashi, 1993).
TABLE I
DISTRIBUTION OF THE EXPERIMENTAL AND CONTROL GROUPS
Initial age for Type of Mating Sacrifice Period of
injection injection age age mating
Control (days) (days) (days) (days)
groups
C60 30 0.9% saline - 60 -
CM113 30 0.9% saline 103 113 10
Experimental
groups
E60 30 Etoposide (VP-16) - 60 -
EM113 30 Etoposide (VP-16) 103 113 10
V60 30 Vehicle - 60 -
VM113 30 Vehicle 103 113 10
C60, V60 and E60 groups, n=6 in each group
CM113, EM113 and VM113 groups, n=10 in each group.
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Tubular diameter. The diameter of semin-
iferous tubule sections was measured uti-
lizing an eyepiece micrometer (x8) at-
tached to a light binocular microscope.
Random measurements of 100 tubules per
animal were done in cross or oblique sec-
tions at x80 magnification. When the sec-
tions were oblique, the minor axis was
measured (Miraglia and Hayashi, 1993;
Botelho Cabral et al., 1997).
Cells of germinal lineage. The percent-
ages of tubular sections containing the
various cell types (Table IV) of the semi-
niferous epithelium were determined by
counting 100-random-transverse or ob-
lique sections in each testis at x1000
magnification (Hayashi and Cedenho,
1980; Miraglia and Hayashi, 1993). B-
type and intermediate spermatogonia
were not distinguished individually and
were added together. Similarly, neither
A0-type and A1-A4 type spermatogonia
were individually differentiated. Sperma-
tids in the steps 1 to 8 were considered
round spermatids and those in the steps 9
to 19 were denominated elongate.
Radioimmunoassay method
Blood was collected
from the abdominal aorta of all animals,
previously anaesthetized, to measure se-
rum testosterone. The serum was main-
tained at -20ºC. Afterwards, the animals
were sacrificed with an exceeding dose of
the anesthetic. Measurements were made
in a single assay by standard radioimmu-
noassay method (Lox et al., 1974).
Reproductive performance
Each of the rats in the
EM113, VM113 and CM113 groups were
mated in individual cages with two multi-
parous female rats for 10 consecutive
days when they were 103 days old, to as-
sess their fertility. The fertility index in
each group was considered as the ratio of
the total quantity of offspring to the total
number of mated female rats (Table V).
The progenies were observed for 30 con-
secutive days in order to obtain informa-
tion about their body weight, viability as
well as their mortality index.
Statistical methods
The Jandel Statistical
SigmaStat software, version 2.0, was uti-
lized. To compare the two sets of groups
of same age (E60, V60 and C60, and
E113, V113 and C113) an analysis of
variance (ANOVA) was performed. All
data obtained from morphometric and ste-
reological studies were submitted to a
Standard One Way ANOVA, excepting the
frequencies of the cellular types of germi-
nal lineage; when the results obtained
were significant or highly significant, all
pairwise multiple-comparison procedures
(Student-Newman-Keuls Method) were
used in the variables. On the other hand,
for the analysis of the frequencies of ger-
minal lineage cell types, a non-parametric
ANOVA on Ranks rather than a Standard
One Way ANOVA was performed. Thus,
when these last data showed significance,
a complementary multiple-comparison test
(Dunn’s method) was applied. In this case,
in spite of the utilization of a non-para-
metric analysis, the values of means are
also presented in Table III, with the pur-
pose of giving an idea on the variability of
these data and also to allow their compari-
son with the data obtained from the litera-
ture.
Results
General aspects of the etoposide-treated
animals
The etoposide-treated al-
bino animals exhibited piloerection and
paleness in the extremities, tail and eyes,
evidencing a probable anemia. Other ad-
verse effects including myocardial infarc-
tion, hypotension, peripheral neuropathy,
ascites, systemic debility and ataxy were
not observed. Some hepatosplenomegaly
was noted. One animal presented anaphy-
lactic shock; it died and was substituted.
In general, the rats showed transient diar-
rhea and some reversible alopecia, side ef-
fects that disappeared after the completion
of the treatment, when the animals were
in adult phase. A decrease of food intake
was another adverse effect observed dur-
ing the treatment; however, there was
some stabilization as there was some re-
TABLE II
BODY WEIGHT AND TESTICULAR MORPHOMETRY IN ALBINO RATS OF THE CONTROL
AND EXPERIMENTAL GROUPS
Body Absolute Relative Major Minor Total testicular
weight testicular testicular axis axis volume
weight weight
Control (g) (g) (g/100g bw) (mm) (mm) (mm3)
groups
C60  235.00 ± 8.03 1.25 ± 0.08 0.57 ± 0.04 18.59 ± 0.34 11.10 ± 0.38 1199.30 ± 105.56
CM113  345.72 ± 20.16 1.58 ± 0.11 0.46 ± 0.05 20.90 ± 0.33 11.96 ± 0.36 1565.33 ± 114.29
Experimental
Groups
E60 145.98 ± 6.22** 0.78 ± 0.08** 0.53 ± 0.03 15.51 ± 0.61** 9.23 ± 0.29** 691.85 ± 58.56**
E60<C60 and V60 E60<C60 and V60 E60<C60 and V60 E60<C60 and V60 E60<C60 and V60
EM113 308.40 ± 8.01* 0.76 ± 0.18** 0.25 ± 0.06** 15.54 ± 1.20** 9.49 ± 0.66** 732.79 ± 168.15**
E113<C113 and V113 E113<C113 and V113 E113<C113 and V113 E113<C113 and V113 E113<C113 and V113 E113<C113 and V113
V60 242.00 ± 9.11 1.22 ± 0.07 0.50 ± 0.07 19.08 ± 0.41 11.20 ± 0.40 1253.18 ± 126.98
VM113 350.80 ± 18.20 1.54 ± 0.13 0.47 ± 0.04 21.00 ± 0.35 11.88 ± 0.29 1551.61 ± 143.45
Values given as mean ± standard error
*p<0.05 (significant).
** p<0.01 (highly significant).
For descriptions of the groups see Table 1.
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covery of body weight noted in 113-day-
old adult rats of the mated etoposide-ex-
perimental group.
Histological analysis and frequencies
of the cellular types of germinal lineage
In the etoposide-experi-
mental group (E60), the most damaged se-
miniferous convoluted tubules showed low
cellular population density with a corre-
sponding enlargement of lumen diameter
and intraepithelial vacuolation (Figures 1,
2, 3). Tubular sections containing only
Sertoli cells (“Sertolization”; Figure 3) as
well as spermatogonia were rarely ob-
served. Although the animals in the E60
group sometimes exhibited normal tubular
sections under the light microscope, py-
knotic nuclei of germinal lineage cells
were observed in other sections, character-
izing the degeneration of the seminiferous
epithelium. Multinucleated formations of
round spermatids and other rare forms of
primary spermatocytes were also noted in
this group (Figures 2 and 4, respectively).
Sometimes, the nuclei of these formations
showed chromatin condensation in one or
several homogeneous masses, surrounding
the nuclear membrane and suggesting apo-
ptosis (Figure 2).
Some sections also dis-
played disorganized cellular associations
corresponding to different stages of the
seminiferous epithelium cycle while oth-
ers exhibited a large quantity of cellular
debris and cells at various phases of
maturation localized in the tubular lumen.
The tubular diameter
(Table III) was largely diminished in both
etoposide-experimental groups (E60 and
EM113) in comparison to the correspon-
dent sham-control and vehicle-experimen-
tal groups.
The frequencies of the
tubular sections containing the various
types of germinal lineage cells are shown
in Table IV. In a hundred sections exam-
ined per testis, the frequencies of all cell
types of germinal lineage exhibited an ac-
centuated reduction in the E60 group,
when compared to both C60 and V60
groups.
In the mated etoposide-
experimental group (EM113), various semi-
niferous tubule sections exhibited similar
qualitative histological characteristics such
TABLE III
TESTICULAR STEREOLOGY IN ALBINO RATS OF THE CONTROL AND EXPERIMENTAL GROUPS
Tubular Siminiferous tubule Interstitial tissue Tubular volumetric Volumetric density
diameter volume volume density of interstitial tissue
Control (µm) (mm3) (mm3) % %
groups
C60 258.86 ± 16.39 840.11 ± 59.25 359.19 ± 43.88 70.00 30.00
CM113 276.60 ± 17.51 1130.32 ± 92.65 435.01 ± 37.26 72.21 27.79
Experimental
groups
E60 195.59 ± 2.81** 468.65 ± 39.04** 223.03 ± 24.95* 67.76** 32.24**
E60<C60 and V60 E60<C60 and V60 E60<C60 and V60 E60<C60 and V60 E60>C60 and V60
EM113 207.17 ± 21.43** 486.28 ± 115.72** 246.51 ± 52.89** 66.36** 33.64**
E113<C113 and V113 E113<C113 and V113 E113<C113 and V113 E113<C113 and V113 E113>C113 and V113
V60 255.42 ± 16.83 875.72 ± 94.65 377.46 ± 60.39 69.88 30.12
VM113 275.80 ± 16.70 1123.36 ± 85.40 428.24 ± 30.54 72.40 27.60
Values given as mean ± standard error
*p<0.05 (significant).
**p<0.01 (highly significant).
Figure 1. Light micrograph of testicular
section of a 60-day-old etoposide-treated
rat. An altered seminiferous tubule showing
low frequency of germinal lineage cells and
many cells with pyknotic nuclei (arrows).
PAS + H (x245).
Figure 2. Light micrograph of portion of se-
miniferous tubule of a 60-day-old etoposide-
treated rat exhibiting intraepithelial vacuola-
tion (asterisks) and a multinucleated forma-
tion of round spermatids (large arrow). Mar-
gined condensations of chromatin are ob-
served in some nuclei of this formation, sug-
gesting apoptosis (small arrows). PAS + H
(x615).
Figure 3. Light micrograph of testicular sec-
tion showing portions of two seminiferous tu-
bules of a 60-day-old etoposide-treated rat.
Both tubules exhibit quantitative alterations of
the germinal lineage cells. The left tubule
shows “Sertolization” of the seminiferous epi-
thelium while the right tubule exhibits a little
hypotrophic epithelium. PAS + H (x240).
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as those observed in the E60 group. How-
ever, tubular sections showing low cell den-
sity, intraepithelial vacuolation (Figure 5)
and “Sertolization” were less frequent in
the 113-day-old than in the 60-day-old eto-
poside-treated experimental animals, al-
though the frequencies of various cell types
of germinal lineage were still low in rela-
tion to both CM113 and VM113 groups
(Table IV). Multinucleated formations of
round spermatids (Figure 2) were very rare
in the EM113 group and those of sperma-
tocytes (Figure 4) were absent.
In addition, some folding
of peritubular tissue was occasionally seen
in rats of the E60 group, while it was not
observed in the animals of the EM113
group. The Leydig cells showed normal
morphology under light microscope in
both etoposide-experimental groups.
The Sertoli cells also
exhibited nuclei with normal morphology
under the light microscope and the fre-
quency of the tubules containing these
cells was also normal in both E60 and
EM113 (Table IV).
The animals of the V60
and VM113 groups (Figure 6) displayed
normal testicular histology, like the C60
and the C113 groups, respectively.
Body and testicular weights
Animals in the E60
group showed a highly significant reduc-
tion of body weight in comparison to the
correspondent C60 and V60 groups, while
those of the EM113 group only exhibited
a significant decrease in relation to the
CM113 and VM113 groups (Table II). In
addition, rats of both E60 and EM113
groups showed highly significant decreases
of the absolute testicular weight in com-
parison with the sham control and vehicle-
experimental groups of the same age.
Consequently, 113-day-old mated etopo-
TABLE IV
FREQUENCIES OF GERMINAL LINEAGE CELL TYPES IN ALBINO RATS OF THE EXPERIMENTAL AND CONTROL
GROUPS (PERCENTAGE OF TUBULES WITH CELL TYPES)
Spermatogonia Only A0-A4 A and B or interm. Primary Secondary Round Elongate Sertoli
(TOTAL) spermatogonia spermatogonia spermatocytes spermatocytes spermatids spermatids cells
(#) (##)
Control
groups
C60 100.00 45.00 54.90 100.00 6.00 75.40 92.40 100.00
CM113 100.00 32.00 68.30 100.00 8.50 100.00 100.00 100.00
Experimental
groups
E60 58.00** 23.80** 34.20** 54.70** 3.00** 40.50** 52.10** 100.00
E60<C60 and V60 E60<C60 and V60 E60<C60 and V60 E60<C60 and V60 E60<C60 and V60 E60<C60 and V60 E60<C60 and V60
EM113 66.80* 26.20* 40.60** 68.80 5.50* 55.50* 85.80 100.00
E113<C113 and V113 E113<C113 and V113 E113<C113 and V113 E113<C113 and V113 E113<C113 and V113
V60 100.00 42.00 58.00 100.00 6.00 76.00 100.00 100.00
VM113 96.00 34.00 66.00 100.00 8.00 98.00 100.00 100.00
Values given as means
(#) percentage of tubules containing only type-A spermatogonia.
(##) percentage of tubules containing type-A and type-B or intermediate spermatogonia.
*p<0.05 (significant).
**p<0.01 (highly significant).
Figure 4. Light micrograph of portion of
seminiferous tubules of a 60-day-old etopo-
side-treated rat showing a multinucleated
formation of primary spermatocytes (arrow).
PAS + H (x615).
Figure 5. Light micrograph of portion of se-
miniferous tubule of a 113-day-old etoposide-
treated rat exhibiting low frequency of germi-
nal lineage cells, intratubular vacuolation (as-
terisks) as well as sloughing cells and cellular
debris in the cellular lumen. PAS+H (x310).
Figure 6. Light micrograph of seminiferous
tubule section of a vehicle-treated rat show-
ing normal aspect. PAS+H (x310).
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side-experimental rats showed a very sig-
nificant reduction of relative testicular
weight (g/100g bw), while 60-day-old eto-
poside-experimental rats did not demon-
strate any statistical difference in relation
to the respective sham-control group and
the vehicle experimental group of the
same age (Table II). The results show that
the differences of the body weight that
were observed between the etoposide-
treated rats and their respective control
rats were more accentuated the younger
the animals. On the contrary, there was no
significant recuperation of the testis
weight in older experimental rats.
Morphometric and stereological analysis
of other parameters
Tables II and III contain
data related to the testicular morphometry
and stereology, obtained from the control
and experimental groups. The values re-
lated to the absolute volume of testicular
components are shown in Table III and
obtained from the data of each respective
volume density shown in the same Table
and from the total testicular volume ex-
hibited in Table II. The majority of the
morphometric and stereological param-
eters showed a highly significant decrease
in both E60 and EM113 groups in com-
parison with the respective C60 and
CM113 groups and the V60 and VM113
groups (Tables II, III). Exceptions were
observed in relation to the volume of in-
terstitial tissue, which only diminished
significantly in the E60 group (Table III)
as well as in relation to the testicular
relative weight (Table II), which did not
exhibit significant alterations in this
group. On the other hand, the volume
density of interstitial tissue showed a
highly significant increase in the E60 and
EM113 groups, in comparison with the
sham-control and vehicle-experimental
groups of the same age. No significant
morphometric and stereological testicular
alterations occurred in the rats of the V60
and VM113 groups, in comparison to re-
spective sham-control groups of the same
age (C60 and CM113).
Serum testosterone level, reproductive
performance and mortality of offspring
The statistical analysis
did not show significant alterations on the
serum testosterone levels in the rats of
E60, V60, EM113 and VM113 experi-
mental groups in comparison with the re-
spective C60 and CM113 sham-control
groups (Table V).
No significant alterations
of the serum testosterone level were ob-
served in the animals of etoposide-experi-
mental groups in comparison to vehicle-
experimental groups of the same age.
The data related to the
reproductive performance of the rats of
the EM113 group showed a highly sig-
nificant decrease of the offspring occur-
rence obtained from the mating of these
rats in comparison to CM113 and VM113
groups. Consequently, the fertility index
of the etoposide-experimental group was
very low (Table V).
The newborn rats exhib-
ited small size, low body weight (Table
V) and cyanosis. There was a 100% mor-
tality of the offspring in a seven-day pe-
riod.
Discussion
Patients in reproductive
age can be exposed to several side effects
when chemotherapeutic agents are admin-
istered for cancer treatment. Since cells
of spermatogenic lineage are especially
vulnerable because they are constantly
under mitosis or meiosis, damage of the
testis can occur and, consequently, a de-
crease or loss of fertility.
The large and efficient
activity of the etoposide in anticancer
therapy has been reported (Relling et al.,
1992), including its utilization in the
treatment of refractory malignant neo-
plasm such as tumor of testicular stroma
cells (Stewart et al., 1993). Etoposide
acts inhibiting the topoisomerase II, an
ATP-dependent nuclear-enzyme that regu-
lates DNA topology by transiently break-
ing and rejoining double-stranded DNA
(Wozniak and Ross, 1983). In mammals,
this derivate of epipodophyllotoxyn inter-
feres with the action of the topoisomerase
II during the process of DNA replication
and transcription. Thus, its chemothera-
peutic efficacy is correlated with its abil-
ity to stabilize the covalent DNA-topoi-
somerase complex and this is the most
probable explanation for this cytotoxicity.
However, the stabilization of the covalent
complex is not sufficient to ensure cell
death, but the activation by etoposide of
specific enzymes and precursors of en-
zymes catalyzes a biochemical cascade of
events culminating with apoptosis (Kauf-
mann, 1998). In normal tissues, the activ-
ity of etoposide varies during the cell
cycle (Heck and Earnshaw, 1986) and in
the S-phase this drug is very toxic (Ma-
raschin et al., 1990). The long-term ad-
ministration of low-daily-dose etoposide
has been discussed and suggested as a
possible superior schedule in treatments
of some neoplasms, provoking less my-
elotoxicity than the standard schedule
(Greco and Hainswort, 1994). The former
schedule was utilized in this report to ex-
amine its toxicity amplitude on the pro-
cess of spermatogenesis.
There is general agree-
ment that various antineoplastic drugs ex-
ert a prejudicial effect on spermatogonia
provoking the death of these cells (Meist-
rich et al., 1982; Russell and Russell,
1991). Besides, differentiated spermatogo-
nia are more sensitive to chemotherapeu-
tic agents than spermatogonia, which are
reserve stem cells (Lu and Meistrich,
1979). The former include types B and
intermediate, as well as the renewing
stem cell categories that consist of four
successive generations of A-type sper-
matogonia (A1-A4; Lu and Meistrich,
TABLE V
SERUM TESTOSTERONE LEVEL AND REPRODUCTIVE PERFORMANCE
IN ALBINO RATS OF THE EXPERIMENTAL AND CONTROL GROUPS
Serum Total Total Index Weight
testosterone number of number of of of the
Control level newborn mated fertility offspring
groups (ng/dl) rats females  (g)
C60 197.00 ± 42.43 no mating no mating no mating -
CM113 191.60 ± 69.82 194 20 9.70 6.22
Experimental
groups
E60 190.60 ± 101.09 no mating no mating no mating -
EM113 274.40 ± 101.20 35** 20 1.75** 4.14**
E113<C113 and V113 E113<C113 and V113 E113<C113and V113
V60 253.40 ± 94.88 no mating no mating no mating -
VM113 220.00 ± 74.86 203 20 10.15 6.30
Values given as mean ± standard error
**p<0.01
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1979; Dym and Clermont, 1987). Our re-
sults showed a significant decrease of tu-
bular sections containing the various ele-
ments of the seminiferous epithelium in
the etoposide-treated rats. This probably
occurred because the testis is a highly
prolific tissue, like the bone marrow, with
fast cellular renewal and, for this reason,
it probably presents a large quantity of
topoisomerase and becomes an easy tar-
get for the etoposide. Highly significant
decrease of the frequencies of tubular
sections containing the various types of
spermatogonia, of primary and secondary
spermatocytes, as well as of round and
elongate spermatids were observed in eto-
poside-treated 60-day-old rat testes. On
the other hand, 113-day-old etoposide-
treated rats showed only significant dimi-
nution of the total number of tubular sec-
tions containing spermatogonia as well as
secondary spermatocytes and round sper-
matids. Moreover, no statistically signifi-
cant alterations of frequencies of tubular
sections with primary spermatocytes and
elongate spermatids occurred in these
animals. The reserve stem cells (A0),
which were less sensible to the drug, pro-
liferated and populated the tubule again
with renewing stem cells (A1-A4). Thus,
an increase of tubules containing these
types of stem cells was noted in the eto-
poside-treated older rats. This may sig-
nify that a light recuperation of the semi-
niferous epithelium occurred since, on the
contrary, in etoposide-treated younger rats
the frequencies of these cellular types
were highly decreased. Otherwise, mor-
phometric and stereological testicular val-
ues pertaining to the EM113 group did
not return to normal level.
Etoposide inhibits pre-
mitotic DNA synthesis more effectively at
stages II–III and IV-VI of the seminiferous
epithelium cycle in which DNA synthesis
of late spermatogonia (intermediate and B-
type spermatogonia) takes place (Parvinen,
1982; Hakovirta et al., 1992). The present
results show that the frequencies of semin-
iferous tubules presenting only A-type
spermatogonia as well as A-type, B-type
and intermediate spermatogonia were
highly reduced in the E-60 group while
they were respectively reduced and highly
reduced in the EM113 group.
However, other pre-mi-
totic peaks of DNA synthesis are also lo-
cated at stages IX, XII, XIV and I, in-
volving A1, A2, A3 and A4 spermatogo-
nia, respectively (Hakovirta et al., 1992).
This fact evinces data related to the evi-
dent diminution of the frequency of the
tubules containing only A-type sper-
matogonia verified in this report.
On the other hand, DNA
synthesis in pre-meiotic spermatocytes is
not as vulnerable to the etoposide action
as pre-mitotic DNA synthesis is. This
might be due to the fact that the role of
topoisomerase II in pre-mitotic DNA syn-
thesis, at determined stages of develop-
ment, is more accentuated than in pre-
meiotic DNA synthesis. Moreover, in pre-
meiotic DNA synthesis other topoiso-
merases can be involved in the process
(Hakovirta et al., 1992). Nevertheless, ac-
cording to our results, etoposide adminis-
tration caused a very accentuated diminu-
tion of primary spermatocytes and of
other more differentiated cells of germi-
nal lineage in etoposide-treated 60-day-
old animals. Probably, the phenomenon
of depletion of maturation, which in-
volves the progressive scarceness of sper-
matocytes and spermatids after the de-
struction of spermatogonia, was also an
important reason for these decreases, act-
ing together with the direct but minor ef-
fect of etoposide on DNA pre-meiotic
synthesis.
In addition to the quan-
titative alterations in the components of
seminiferous epithelium, qualitative mor-
phological alterations such as intraepithe-
lial vacuolation, presence of multinucle-
ated cells from round spermatids and pri-
mary spermatocytes, low cellularity of se-
miniferous tubules, germinal lineage cells
with pyknotic nuclei and tubular “Ser-
tolization” were also observed. The oc-
currence of multinucleated formations has
been observed in testes of prepuberal
normal rats (Miraglia and Hayashi, 1993),
of elderly people (Holstein and Eckmann,
1986), in adverse conditions and patho-
logical circumstances (Kaya and Har-
rison, 1975; Hayashi and Cedenho, 1980;
Martinova et al., 1989; Miraglia and
Hayashi, 1993; Scott et al., 1996; Bo-
telho Cabral et al., 1997; Sasso-Cerri et
al., 2001). However, in this work the oc-
currence of these formations from pri-
mary spermatocytes was much rarer than
from round spermatids. During the re-
spective phases of the normal process of
spermatogenesis, intercellular bridges
connect groups of each specific cell type
of the germinal lineage among them.
These bridges remain intact until the later
spermatids are released into the tubular
lumen, to be, then, the free spermatozoa.
Otherwise, multinucleated formations of
round spermatids are groups of these
cells that were unable to separate from
each other during the spermiogenesis
(Miraglia and Hayashi, 1993). This hap-
pens because breakdown failures in the
intercellular bridges take place (Holstein
and Eckmann, 1986). Thus, these cells
undergo karyokinesis without any cytoki-
nesis and, then, coalesce themselves
(Kaya and Harrison, 1975). Multinucle-
ated formations from round spermatids,
suggesting apoptosis, were also relatively
common in the 60-day-old etoposide-
treated rats. Cancer chemotherapeutic
drugs, including etoposide, are very po-
tent inducers of apoptosis in male rat
germ cells (Sjöblom et al., 1998). Death
of these multinucleated formations may
have occurred due to apoptosis, which is
a way to eliminate damaged germ cells,
as it is a controlled form of cell selection
acting as a molecular control point regu-
lating physiological processes, toxicities
and diseases through cell deletion
(Corcoran et al., 1994).
The presence of in-
traepithelial vacuoles was probably a
consequence of the death of germinal lin-
eage cells resulting in large spaces be-
tween contiguous Sertoli cells. Thus,
these vacuoles were possibly extra-cellu-
lar in relation to the Sertoli cell, due to
the lack of elements of the seminiferous
epithelium. Studies by transmission elec-
tron microscope have shown that the
vacuoles can also be aggregated within
the seminiferous epithelium and arranged
in sequential series along the course of
the junctional complex between neighbor-
ing Sertoli cells (Kerr et al., 1979; 1987).
The results demonstrated
that the etoposide had a negative action
on the seminiferous epithelium; it fre-
quently provoked a moderated tubular
hipocellularity and sometimes an accentu-
ated tubular atrophy, observed in 113 and
60-day-old etoposide-treated rats. Conse-
quently, morphometric and stereological
testicular alterations occurred in both
groups. Lower and higher daily doses of
etoposide than those utilized in this ex-
periment can induce testicular and epid-
idymal atrophies as well as a suppression
of spermatogenesis with decrease of the
total number of spermatozoa produced
(Takahashi et al., 1986a; Kadota et al.,
1989).
The evident diminution
of germinal lineage cells observed had
repercussions on the reproductive capac-
ity of the 113-day-old etoposide-treated
rats and provoked a decrease of their fer-
tility index. In these cases, sterility and
temporary infertility are probably related
to the survival of testicular reserve stem
cells as well as to the number of regener-
ating stem cells and the kinetics of their
differentiation into functional spermato-
zoa.
Chemotherapy can in-
duce interstitial fibrosis and may reduce
the percentage of seminiferous tubules
with evident spermatogonia. However,
many testicular alterations can be re-
versed after the treatment, depending on
the elapsed time (Hensle et al., 1984).
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The low fertility index
observed in 113-day-old etoposide-treated
male rats occurred due to deficient sper-
matogenesis resulting in a decrease of
functional spermatozoa. Damage and death
of differentiated spermatogonia constituted
the main cause. However, fetal mortality
might also have contributed to the ob-
served small progeny, as etoposide is a
clastogenic (Maraschin et al., 1990; Mar-
tin et al., 1999) and mutagenic drug
(Sjöblom et al., 1994). It is possible that
chromosome-type aberrations and frequent
chromatid-type lesions occurred in cells of
the spermatogenic lineage and probably
neither occurred at random (Maraschin et
al., 1990). In the present study, the off-
spring from untreated multiparous normal
female rats mated with etoposide-treated
male rats died within 7 days after birth.
High fetal mortality and many congenital
malformations have been noted in the
progeny from pregnant rats treated with
etoposide (Takahashi et al., 1986b).
It has also been reported
that anticancer agents can affect Leydig
cells (Barcellona and Brinkley, 1973;
Parvinen, 1979) and, consequently, ste-
roidogenesis. Stereological and ultrastruc-
tural studies about these subjects are be-
ing carried out. Daily manipulation of
rats has been cited as another factor that
might modify the serum testosterone level
(Grota, 1971). No statistically significant
alterations of serum testosterone level
were noted in the 60-day-old and 113-
day-old rats treated with etoposide or ve-
hicle for 30 consecutive days from 30
days of age.
In summary, the long-
term administration of low daily doses of
etoposide to rats from prepuberal phase in-
duced accentuated testicular morphometric
and stereological alterations in the adult
phase. These morphological alterations
were not specific and were similar to those
caused by other anticancer agents. Prob-
ably, differentiated spermatogonia (B-
type, intermediate, A1-A4 types) were the
most affected cells because they have
high quantities of topoisomerase II, the
main target of etoposide action. Previous
reports have demonstrated that the forma-
tion of a cleavable etoposide-topoisom-
erase II-DNA complex triggers cytotoxic-
ity but does not constitute the immediate
cause of cellular death; on the other
hand, there is a high degree of correlation
between etoposide-induced sister chroma-
tid exchanges and cytotoxicity (Chatterjee
et al., 1990). Sister chromatid exchanges
may also include non-homologous recom-
bination in which unequal exchange of
genetic material could lead to loss or
gain of genetic sequences from progeny
cells. This fact could lead to essential
gene inactivation, subsequent depletion of
essential gene product and, finally, cellu-
lar death (Berger et al., 1991). The fre-
quencies of other more differentiated
cells of germinal lineage also diminished,
which might have been due to the cas-
cade cellular depletion phenomenon since
they derive from progressive differentia-
tion of spermatogonia, but the direct ac-
tion of etoposide on those cells should
not be excluded. The rats showed restora-
tion of body weight, and some light recu-
peration of the seminiferous epithelium
could be observed. Otherwise, their re-
productive performance was very low.
Thus, although a reduced fertility index
has been noted when mating etoposide-
treated rats with normal multiparous fe-
males, it is also important to consider the
high number of early deaths of cyanotic
and little pups that occurred soon after
birth. Also, it is possible that a percent-
age of pre- or post-implantation embryo-
nary loss could have happened since eto-
poside is a clastogenic and mutagenic
drug, deserving further investigation.
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